A small protein involved in neurodegeneration leading to Parkinson’s disease also drives a type of skin cancer known as melanoma, new research led by Oregon Health & Science University finds.
Health Professionals
HOPA 2025: Advancements and Challenges in Neoadjuvant Therapy for Regional Melanoma
Christine Barrett, PharmD, BCOP, addressed advances in the treatment of stage III melanoma that provide the potential to improve long-term outcomes by enhancing immune response, tailoring surgical approaches, and refining patient selection strategies.
Confirmed Benefit of Adjuvant Therapy, Not Nodal Dissection, in Stage III Melanoma
ATHENS, Greece — Real-world data confirm that complete nodal dissection following a positive sentinel lymph node biopsy in patients with stage III melanoma and micrometastases does not significantly reduce the risk for relapse or death.
HOPA 2025: Advancements and Challenges in Neoadjuvant Therapy for Regional Melanoma
Christine Barrett, PharmD, BCOP, addressed advances in the treatment of stage III melanoma that provide the potential to improve long-term outcomes by enhancing immune response, tailoring surgical approaches, and refining patient selection strategies.